Преемник

Преемник

Результаты (английский) 1:

Successor

Результаты (английский) 2:

This program is the base of the pharmaceutical industry development plan, for the industrial development environment and the needs of the industry, such as technical and regulatory guidance and industrial development policy promotion. Through this program to promote manufacturers to invest in research and development and production line construction of more than 100 million yuan, technical guidance products on the market, it is expected that three years can reach more than 46,000 yuan output value, improve the domestic characteristics of the production line nano technology drug development, GMP hardware and software guidance to drive 4 million yuan investment, to assist manufacturers in line with ich norms, strengthen international cooperation in products. This year's implementation results, completed 13 technical consulting diagnostic assessment, technology development related lectures 2 sessions, development of product technical analysis and evaluation 4, tutoring manufacturers to develop international market niche drugs 4 pieces, complete ICH compliance difference analysis visit 16 pieces, export destination country GMP specification tutoring 4, export topic seminar / expert symposium 6 times, the international media widely announced 4, held 3 shifts of pharmaceutical industry technical personnel training courses, training 115 people, held a class A pioneer chemical industry raw materials declaration inspection work advocacy note 3 times, check the pioneer chemical industry raw materials manufacturers (including A, B) up to 140, processing foreign 145 cases of government consultation on information of import and export manufacturers, completion of 5 consultation interviews with agricultural ring drug manufacturers, assistance in obtaining 2 government plans, 1 to help solve the problem of drug release, 1 exhibition of production and academic cooperation, 2 seminars and exchanges, 2 good laboratory exchanges, Visit the exhibition exchange 1 time, Cambodian officials vs. manufacturer media meeting 3 times, animal drug manufacturers consultation interview 3, complete the development and evaluation of dynamic drug products 1 piece, animal drug development related activities 3 times, held 2 seminars, results promotion 1 time.

Результаты (английский) 3:

Heir